Nilogen Oncosystems reposted this
We’re excited to continue sharing our innovations at SITC 2024! On 9th November 2024, join us to explore our cutting-edge research: 🔬 Advancing Cancer Therapy: High-Content Imaging for Precise Tumor Cell Killing Analysis in Patient-Derived Tumoroids Uncover how high-content imaging is enhancing our understanding of tumor cell killing with patient-derived tumoroids. 🔬 Enhancing T Cell Persistence in Adoptive Cell Therapy: Leveraging Tumoroid-Based ex-vivo Assays See how our tumoroid-based ex-vivo assays are improving preclinical evaluation of T cell persistence in adoptive cell therapies. 🔬 Assessing Immunotherapy Efficacy with the 3D-EXplore Platform: Focus on PD-1/PD-L1 Inhibitors in NSCLC Discover insights into the effectiveness of PD-1/PD-L1 inhibitors using Nilogen Oncosystems’ 3D-EXplore Platform for NSCLC tumors. 🔬 Predictive Modeling of Immune-Related Adverse Events Using Tumoroids Learn how our tumoroid models are advancing predictive modeling of immune-related adverse events in immunotherapy. Join us at Booth #928 to dive into these groundbreaking studies and see how Nilogen is pushing the boundaries of cancer research and therapy.